Immatics at the Keystone Symposium “Antibodies as Drugs” (Feb 2-6) in Santa Fe, NM (USA)
Discovery, Translation, Commercialization: Developing CAR-T into viable, accessible therapies
Meet Immatics at the Keystone Symposium “Antibodies as Drugs” in Santa Fe, New Mexico, and deep dive with us into the exciting field of antibody driven sciences: From basic to translational to clinical for the benefit of patients!
Wednesday, Feb 5, 5pm – 7pm
Plenary PM: T Cell Targeting for Cancer Therapy
TCR-Based Cancer Immunotherapies to Novel pMHC Targets
Speaker: Amir Alpert, Assoc. Director Immunology
We are looking forward to seeing you there.
Further information on Keystone Symposia and the Antibodies as Drugs Conference here.